Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalini Sachana

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Toxicology and Applied Pharmacology|February 25, 2018
Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methodsAnna Bal-Price, Francesca Pistollato, Magdalini Sachana, et al.
Basic & Clinical Pharmacology & Toxicology|January 15, 2014
Diazoxon disrupts the expression and distribution of βIII-tubulin and MAP 1B in differentiating N2a cellsMagdalini Sachana, Erasmia Sidiropoulou, John Flaskos, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 27, 2018
International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity TestingMagdalini Sachana, Anna Bal-Price, Kevin M Crofton, et al.
ALTEX|July 18, 2018
Investigating cell type specific mechanisms contributing to acute oral toxicityPilar Prieto, Rabea Graepel, Kirsten Gerloff, et al.
Biochemical Pharmacology|February 28, 2006
Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: effects on MAP kinase (ERK 1/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activityAlan J Hargreaves, Maxine J Fowler, Magdalini Sachana, et al.
Neurotoxicology|May 24, 2016
Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicityAnna Bal-Price, Pamela J Lein, Kimberly P Keil, et al.
Frontiers in Plant Science|June 18, 2020
Summary of Discussions From the 2019 OECD Conference on RNAi Based PesticidesMichael L Mendelsohn, Achim Gathmann, Dimitra Kardassi, et al.
Cells|October 14, 2022
Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway FrameworkMuhammad Ali Shahbaz, Francesca De Bernardi, Arto Alatalo, et al.
Frontiers in Public Health|June 7, 2021
Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway FrameworkPenny Nymark, Magdalini Sachana, Sofia Batista Leite, et al.
ALTEX|March 7, 2021
Understanding COVID-19 through adverse outcome pathways - 2nd CIAO AOP Design WorkshopClemens Wittwehr, Maria João Amorim, Laure-Alix Clerbaux, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Toxicology and Applied Pharmacology|February 25, 2018
Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methodsAnna Bal-Price, Francesca Pistollato, Magdalini Sachana, et al.
Basic & Clinical Pharmacology & Toxicology|January 15, 2014
Diazoxon disrupts the expression and distribution of βIII-tubulin and MAP 1B in differentiating N2a cellsMagdalini Sachana, Erasmia Sidiropoulou, John Flaskos, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 27, 2018
International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity TestingMagdalini Sachana, Anna Bal-Price, Kevin M Crofton, et al.
ALTEX|July 18, 2018
Investigating cell type specific mechanisms contributing to acute oral toxicityPilar Prieto, Rabea Graepel, Kirsten Gerloff, et al.
Biochemical Pharmacology|February 28, 2006
Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: effects on MAP kinase (ERK 1/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activityAlan J Hargreaves, Maxine J Fowler, Magdalini Sachana, et al.
Neurotoxicology|May 24, 2016
Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicityAnna Bal-Price, Pamela J Lein, Kimberly P Keil, et al.
Frontiers in Plant Science|June 18, 2020
Summary of Discussions From the 2019 OECD Conference on RNAi Based PesticidesMichael L Mendelsohn, Achim Gathmann, Dimitra Kardassi, et al.
Cells|October 14, 2022
Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway FrameworkMuhammad Ali Shahbaz, Francesca De Bernardi, Arto Alatalo, et al.
Frontiers in Public Health|June 7, 2021
Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway FrameworkPenny Nymark, Magdalini Sachana, Sofia Batista Leite, et al.
ALTEX|March 7, 2021
Understanding COVID-19 through adverse outcome pathways - 2nd CIAO AOP Design WorkshopClemens Wittwehr, Maria João Amorim, Laure-Alix Clerbaux, et al.
Pageof 5